{
    "organizations": [],
    "uuid": "3627cef1de35efd051d011f6f1bad1e87b75a9a0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cantargia-european-patent-for-haem/brief-cantargia-european-patent-for-haematological-cancers-remains-in-force-idUSFWN1PI0TC",
    "ord_in_thread": 0,
    "title": "BRIEF-Cantargia: European Patent For Haematological Cancers Remains In Force",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - CANTARGIA AB:\n* CANTARGIAâ€˜S EUROPEAN PATENT FOR HAEMATOLOGICAL CANCERS REMAINS IN FORCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-23T21:07:00.000+02:00",
    "crawled": "2018-01-24T15:40:16.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "cantargia",
        "ab",
        "cantargia",
        "european",
        "patent",
        "haematological",
        "cancer",
        "remains",
        "force",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}